Sensei Biotherapeutics, Inc.
PIKTOR
endometrial cancer
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for PIKTOR in endometrial cancer are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Phase 2 in endometrial cancer reads out EOY 2026”